Gene Query: MRM1

Dataset Description Geneva Score
Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer (FFPE RNA-Seq II) 79.6
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 7.85
Identification of Nrf2 regulated genes by RNA sequencing 5.57
Nrf2 regulated genes in A549 cells 5.57
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 4.97
The landscape of alternative splicing in aggressive prostate cancers 4.94
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 4.88
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 4.66
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 4.33
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 4.33
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 4.26
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 4.0
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 3.9
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 3.72
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 3.61
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 3.6
Transcriptome analysis of SKI knock-out in HL60 cells 3.51
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 3.51
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 3.46
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 3.38
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 3.38
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 3.37
RNA seq with AML (NB4) cells upon FTO inhibition 3.24
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 3.16
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 3.16
U1 snRNP telescripting regulates size-function stratified human genome 3.14
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 3.14
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 3.14
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 3.09
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 3.09
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 3.04
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 3.04
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 2.98
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 2.75
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 2.69
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 2.66
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 2.57
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 2.42
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 2.42
Modulation of nonsense-mediated decay by rapamycin 2.41
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 2.37
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 2.36
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 2.35
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.32
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 2.27
Global gene expression profile of dasatinib-resistant RCH-ACV cells 2.25
Genome-wide discovery of human splicing branchpoints [RNAse] 2.19
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 2.16
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 2.16
SRSF2 mutations impair hematopoiesis and alter exon recognition 2.15
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 2.1
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 2.09
TGF-β promotes genomic instability after loss of RUNX3 2.09
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 2.08
A549 cells and MSR-A549 cells 2.08
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 2.06
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 2.06
G-quadruplex structures mark human regulatory chromatin 2.05
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 2.01
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 2.01
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 2.01
Genome-wide discovery of human splicing branchpoints 1.95
Impact of dieldrin on transcription in Jurkat T cells 1.93
SNHG5 siRNA knock down in HCT116 cells 1.91
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 1.9
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 1.89
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.82
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 1.81
Transcriptome sequencing of K-562 cells 1.8
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 1.73
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 1.73
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 1.73
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 1.71
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 1.65
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 1.63
Differentially expressed genes post knock down of lincDUSP26 1.59
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 1.55
Gene expression profiling of leukemia cells following asparagine depletion 1.55
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 1.55
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 1.54
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 1.52
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 1.52
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 1.5
A Unique Epigenomic Landscape Defines Human Erythropoiesis 1.5
Identification of global regulators of T-helper cell lineage specification 1.48
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 1.48
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 1.46
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 1.45
U2AF1 mutations alter splice site recognition in hematological malignancies 1.45
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 1.43
Accurate annotation of human protein-coding small open reading frames 1.42
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 1.42
RNAseq Study in CC-671 Treated Cal-51 Cells 1.39
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 1.39
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 1.38
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 1.36
Functional role of SLIT2 and ROBO1 in trophoblasts 1.34
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 1.34
RNA-seq analyisis of PUM2 knockout cells 1.34
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 1.34
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 1.34
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 1.34
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 1.33
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 1.33
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 1.32
Seletive inhibition of CDK9 in DLBCL cell lines 1.31
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 1.29
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 1.29
Co-transcriptional loading of RNA export factors shapes the human transcriptome 1.28
RNAseq of HEK293 cells after Chtop knockdown 1.28
Identification of transcription start sites for human A549 cell line using ReCappable-seq 1.27
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 1.26
RNA-seq of tumor cells following angiopellosis extravasation 1.25
Dtx3L and Androgen Signaling in Prostate Cancer 1.25
Gene expression analysis of the impact of TDP-43 knockout in human cells. 1.24
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 1.24
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 1.24
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 1.24
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 1.23
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 1.22
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 1.22
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 1.22
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 1.19
Human embryonic stem cells in E8 and AKIT culture medium 1.19
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 1.19
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 1.17
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 1.17
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 1.16
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 1.15
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 1.15
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 1.15
Discovering human diabetes-risk gene function with genetics and physiological assays 1.14
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 1.14
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 1.12
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 1.11
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 1.1
HEXIM1 is induced by DHODH inhibition to suppress melanoma 1.1
Oncogenic roles of ARID5B in T-ALL 1.1
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 1.1
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 1.09
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 1.08
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 1.08
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 1.08
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 1.08
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 1.08
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 1.07
Lysine benzoylation is a novel histone mark 1.07
Lysine benzoylation is a novel histone mark [RNA-seq] 1.07
Bone marrow derived human B cells [normal proB] 1.06
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 1.05
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 1.04
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 1.03
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 1.03
ENCODE Cold Spring Harbor Labs Long RNA-seq 1.03
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 1.02
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 1.02
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 0.99
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 0.99
The cohesin complex prevents Myc-induced replication stress 0.99
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 0.99
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 0.98
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 0.98
Spliceosomal disruption of the non-canonical BAF complex in cancer 0.98
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.98
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 0.97
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 0.97
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 0.97
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 0.97
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 0.97
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 0.97
Silencing p300 in MCF7 cells to study expression and alternative splicing 0.96
RNA-seq analysis of differentiating human erythroblasts 0.96
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 0.94
Hijacking of stress response machinery by oncogenes in acute leukaemia 0.94
Glioblastoma stem cells infected by ZIKA virus 0.91
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 0.91
RNA-seq analysis of control and Myc-induced U2OS cells 0.91
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 0.9
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.89
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.89
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 0.88
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 0.88
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.88
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.88
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 0.87
Differential gene expression of human melanoma cells [RNA-seq] 0.87
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 0.87
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 0.87
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 0.87
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 0.86
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 0.84
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 0.84
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 0.83
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 0.83
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 0.83
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 0.83
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.83
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 0.82
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 0.82
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 0.82
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 0.82
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 0.82
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 0.81
RNA-seq analysis of AML cells in response to ASLAN003 0.8
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.8
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 0.8
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.79
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.79
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 0.79
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 0.79
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 0.79
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 0.78
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 0.77
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 0.77
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 0.77
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.76
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 0.76
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 0.76
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 0.75
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 0.75
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 0.75
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 0.75
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 0.74
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 0.74
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 0.74
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.74
Gene expression analysis upon mtDNA depletion 0.74
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 0.73
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 0.73
Total RNA-seq in ALL-SIL upon JQ1 inhibition 0.73
Effect of Influenza virus infection on lncRNA expression in A549 cells 0.72
IDH3a KO RNA-seq 0.72
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 0.72
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 0.72
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 0.71
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 0.71
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 0.71
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 0.7
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 0.7
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 0.7
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 0.7
Real-time observation of light-controlled transcription in living cells 0.7
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 0.69
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 0.69
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 0.68
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 0.68
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 0.68
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.67
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 0.67
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 0.67
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.66
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 0.66
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 0.66
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 0.65
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 0.65
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 0.64
Identification of long noncoding RNAs in T-ALL cell lines 0.64
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 0.64
Comprehensive comparative analysis of 5’ end RNA sequencing methods 0.64
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 0.63
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 0.63
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.63
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 0.63
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 0.63
hnRNP C is a key regulator of protein synthesis in mitosis 0.62
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 0.62
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 0.62
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 0.62
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 0.62
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 0.62
MeRIP-seq for heat shock in B-cell lymphoma cells 0.62
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 0.62
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 0.61
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 0.61
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 0.61
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 0.61
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 0.6
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 0.6
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 0.6
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 0.6
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 0.6
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 0.6
High-throughput sequencing of pluripotent cells 0.59
Mutational landscape of splicing genes and functional consequences across 33 cancer types 0.59
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.59
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 0.59
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 0.58
RNAseq of T-ALL upon long non coding rna purturbation 0.58
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 0.58
Functional significance of the HIV-1 Tat signature amino acid residues 0.58
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 0.57
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 0.56
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 0.55
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 0.55
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 0.55
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 0.55
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 0.55
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 0.55
Gene expression in GBM with Cav3.2 inhibition 0.55
HNF1A deficiency impairs β-cell fate, granule maturation and function 0.55
Transcriptome analysis upon C6orf203 silencing 0.54
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 0.54
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 0.54
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 0.54
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 0.53
RNA-seq of naive and primed ES cells 0.53
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 0.52
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 0.52
ARS2 is a general suppressor of pervasive transcription [RNAseq] 0.52
Proteomics identifies a marker signature of MAPKi resistance in melanoma 0.52
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 0.52
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.52
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.52
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 0.52
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 0.51
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 0.51
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 0.51
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 0.51
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 0.5
p53 activity results in DNA replication fork processivity 0.5
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 0.5
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 0.5
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 0.5
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 0.5
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 0.49
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 0.49
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 0.49
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.49
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 0.49
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.49
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.48
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 0.48
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 0.48
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 0.47
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.47
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 0.46
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 0.46
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.46
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.46
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 0.45
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 0.45
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.45
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.45
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 0.45
Global analysis of enhancer targets: Mosaic-seq 0.44
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 0.44
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.44
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.43
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.43
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.43
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.43
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.43
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 0.43
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.42
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 0.42
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 0.42
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 0.41
KSDM1b Role in Ewing Sarcoma 0.41
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 0.4
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.4
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 0.39
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.39
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 0.38
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 0.38
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 0.38
RNA polymerase in pre-B-ALL cell lines 0.38
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 0.37
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 0.37
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 0.37
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 0.35
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.34
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.34
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.34
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.34
JAK dependent survival of ALK- ALCL 0.33
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 0.33
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 0.33
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 0.32
Copper Regulation of HIF-1 Transcription Activity 0.32
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 0.32
Targeted enhancer activation by a subunit of the integrator complex 0.31
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 0.31
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 0.31
Human cells contain natural double-stranded RNAs with potential regulatory capacity 0.3
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 0.3
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.29
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.29
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 0.29
Effect of drugs on transcriptomic profiles 0.29
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.29
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 0.29
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 0.28
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.27
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.27
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.27
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.27
Illumina Total RNA-seq in HeLa 0.26
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.26
H1609088 Human RNA-Sequencing 0.26
A transcriptome-wide divergence in protein translation scales with LIN28B expression 0.26
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 0.26
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 0.26
Silencing SPIB in attached and floating state of H1703 lung cancer cells 0.25
LIN28A modulates splicing and gene expression programs in breast cancer cells 0.25
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 0.25
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 0.25
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 0.24
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 0.24
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.23
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 0.22
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 0.22
TT-Seq captures the human transient transcriptome 0.22
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.22
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.22
The cytokine environment influence on human skin-derived T cells 0.22
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 0.21
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 0.21
Targeting MTHFD2 in Acute Myeloid Leukemia 0.21
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.21
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.2
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 0.2
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.19
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.19
Loss of CREBBP results in gene expression repression in lymphoma cells 0.19
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.19
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.19
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.19
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.18
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 0.18
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 0.18
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 0.17
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 0.17
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 0.17
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.17
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.17
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 0.17
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.16
Molecular analysis of renal cell carcinoma with unclassfied histology 0.16
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 0.16
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 0.16
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.15
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 0.15
UV_24h_GRO-Seq 0.15
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.15
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 0.15
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.14
Polarized B -cell functions 0.14
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.14
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 0.13
RNA-seq of Single-Cell Genotyping of Transcriptomes 0.13
Single-Cell Genotyping of Transcriptomes 0.13
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.13
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.13
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.12
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 0.12
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 0.11
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.11
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.11
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 0.11
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 0.11
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.1
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 0.1
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.1
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 0.1
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 0.1
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 0.09
MHC Transcriptomic landscape at haplotype-specific resolution 0.09
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.09
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.09
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.08
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 0.08
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.07
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.07
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.07
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.07
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.07
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.06
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.06
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.06
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.06
Effect of BB608 on Gene Expression in HNSCC Cell Line 0.05
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 0.05
The role of m6A/m-RNA methylation in stress response regulation 0.04
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.04
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 0.04
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 0.04
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.03
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.03
Exploring ILF2 regulatory genes by next-generation sequencing 0.02
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.02
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.02
Impact on erythroid progenitor type on erythroid differntiation 0.02
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 0.01
RNA-seq data from human lymphoma cell lines 0.01
ChIP-seq and RNA-seq from human lymphoma cell lines 0.01
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 0.01
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.0
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.0
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.0
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation